ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total current liabilities

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥455.2B
P/E ratio
43.4x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Dec 31, 202560,137+29.54%
Dec 31, 202446,423-17.27%
Dec 31, 202356,111+8.30%
Dec 31, 202251,809+2.18%
Dec 31, 202150,703+1.19%
Dec 31, 202050,107-6.22%
Dec 31, 201953,433-3.23%
Dec 31, 201855,215+1.73%
Dec 31, 201754,274+15.54%
Dec 31, 201646,975+28.77%
Mar 31, 201636,481+1.65%
Mar 31, 201535,890

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat